Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022)
Spero Therapeutics' (SPRO) quarterly Preferred Shares came in at $2000.0 in Q2 2022, down 33.33% YoY from $3000.0 in Q2 2021, and down 33.33% on a QoQ basis from $3000.0 in Q1 2022.
Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022) Analysis & Trends
Spero Therapeutics (SPRO) has 3 years of Preferred Shares data on file, last reported at $2000.0 in Q2 2022.
- Quarterly Preferred Shares fell 33.33% year-over-year to $2000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $2000.0 (down 33.33% YoY) and the FY2021 annual result came in at $3000.0, changed 0.0% from the prior year.
- Preferred Shares fell to $2000.0 in Q2 2022, from $3000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $3000.0 in Q3 2020 to a low of $2000.0 in Q2 2022.
- A 3-year average of $2875.0 and a median of $3000.0 in 2020 frame the typical range for Preferred Shares.
- Annual changes were most pronounced in 2021 — Preferred Shares changed 0.0% — and 2022, when it sank 33.33%.
- Tracing SPRO's Preferred Shares over 3 years: stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then plunged by 33.33% to $2000.0 in 2022.
- The last three Preferred Shares figures came in at $2000.0 (Q2 2022), $3000.0 (Q1 2022), and $3000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Spero Therapeutics | 70.72 Mn | 19.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 2,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |